Extension of Time to File SOU

NEPHROCLEAR

Astute Medical, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88563718
LAW OFFICE ASSIGNED LAW OFFICE 113
MARK SECTION
MARK NEPHROCLEAR (see, http://uspto.report/TM/88563718/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT NEPHROCLEAR
OWNER SECTION (current)
NAME Astute Medical, Inc.
MAILING ADDRESS 3550 General Atomics Court, Bldg 02/620
CITY San Diego
STATE California
ZIP/POSTAL CODE 92121
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Astute Medical, Inc.
MAILING ADDRESS 3550 General Atomics Court, Bldg 02/620
CITY San Diego
STATE California
ZIP/POSTAL CODE 92121
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Maury M. Tepper, III
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE mtepper@teiplaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tmorris@teiplaw.com
CORRESPONDENCE INFORMATION (proposed)
NAME Maury M. Tepper, III
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE mtepper@teiplaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tmorris@teiplaw.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Chemical reagents and laboratory reagents for medical, medicinal pharmaceutical and veterinary use, namely, for use in the preparation of in vitro diagnostic kits; diagnostic preparations for medical, medicinal pharmaceutical and veterinary use in the field of in vitro diagnostics; immunoassay kits consisting primarily of immunological reagents for medical diagnostic use; medical diagnostic test strips for immunological analyses
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 010
CURRENT IDENTIFICATION Medical instruments and apparatus used to detect markers for medical use in the field of in vitro diagnostics; medical and veterinary apparatus and instruments for diagnostic detection of biological molecules; Laboratory instruments and apparatus, namely, test kits comprised primarily of medical diagnostic apparatus used to detect markers, test strips, test cassettes, pipettes, test tubes, vials, and laboratory cards for diagnostic indicator purposes for immunological analysis; immunology analyzers for in vitro diagnostic use
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 4
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 01/07/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
SIGNATURE /JOSEE SANCHEZ/
SIGNATORY'S NAME Josee Sanchez
SIGNATORY'S POSITION Senior Director, Trademark
DATE SIGNED 01/03/2022
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Mon Jan 03 14:24:24 ET 2022
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XXX-
20220103142424354613-8856
3718-800acd9b0d799b7f6e63
5d4715de11fb3d7da1fbf7067
6e3dbb7b6141f7331ee9-CC-2
4212935-20220103110843562
991



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: NEPHROCLEAR (see, http://uspto.report/TM/88563718/mark.png)
SERIAL NUMBER: 88563718

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Astute Medical, Inc., having an address of
      3550 General Atomics Court, Bldg 02/620
      San Diego, California 92121
      United States
      Email: XXXX
Proposed: Astute Medical, Inc., having an address of
      3550 General Atomics Court, Bldg 02/620
      San Diego, California 92121
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 01/07/2020.

For International Class 005:
Current identification: Chemical reagents and laboratory reagents for medical, medicinal pharmaceutical and veterinary use, namely, for use in the preparation of in vitro diagnostic kits; diagnostic preparations for medical, medicinal pharmaceutical and veterinary use in the field of in vitro diagnostics; immunoassay kits consisting primarily of immunological reagents for medical diagnostic use; medical diagnostic test strips for immunological analyses

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 010:
Current identification: Medical instruments and apparatus used to detect markers for medical use in the field of in vitro diagnostics; medical and veterinary apparatus and instruments for diagnostic detection of biological molecules; Laboratory instruments and apparatus, namely, test kits comprised primarily of medical diagnostic apparatus used to detect markers, test strips, test cassettes, pipettes, test tubes, vials, and laboratory cards for diagnostic indicator purposes for immunological analysis; immunology analyzers for in vitro diagnostic use

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the fourth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Maury M. Tepper, III
      PRIMARY EMAIL FOR CORRESPONDENCE: mtepper@teiplaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmorris@teiplaw.com

Correspondence Information (proposed):
      Maury M. Tepper, III
      PRIMARY EMAIL FOR CORRESPONDENCE: mtepper@teiplaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmorris@teiplaw.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /JOSEE SANCHEZ/      Date Signed: 01/03/2022
Signatory's Name: Josee Sanchez
Signatory's Position: Senior Director, Trademark
Signature method: Sent to third party for signature

PAYMENT: 88563718
PAYMENT DATE: 01/03/2022

Serial Number: 88563718
Internet Transmission Date: Mon Jan 03 14:24:24 ET 2022
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-202201031424243
54613-88563718-800acd9b0d799b7f6e635d471
5de11fb3d7da1fbf70676e3dbb7b6141f7331ee9
-CC-24212935-20220103110843562991




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed